LXRX — Lexicon Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $662.98m
- $523.81m
- $49.80m
Lexicon Pharmaceuticals posts Q2 net loss
Brief: Lexicon Pharmaceuticals Q2 EPS USD -0.07
Lexicon Pharmaceuticals Inc expected to post a loss of 5 cents a share - Earnings Preview
Lexicon Pharmaceuticals Inc expected to post a loss of 5 cents a share - Earnings Preview
Brief: Lexicon Pharmaceuticals Completes Enrollment Of Pivotal Phase 3 Sonata-Hcm Study Of Sotagliflozin In Symptomatic Non-Obstructive And Obstructive Hypertrophic Cardiomyopathy (Hcm)
Lexicon Pharmaceuticals Q1 net loss narrows
Brief: Lexicon Pharmaceuticals Q1 EPS USD -0.01
Brief: Lexicon Pharmaceuticals And Novo Nordisk Announce Initiation Of Phase 1 Study With Oral Obesity Drug Candidate LX9851
Lexicon Pharmaceuticals Q4 net loss narrows on lower R&D spend
Brief: Lexicon Pharmaceuticals Q4 EPS USD -0.04
U.S. STOCKS ON THE MOVE-Church & Dwight, Tesla, Oppenheimer
U.S. STOCKS ON THE MOVE-Charter Communications, Western Digital, Regeneron
U.S. STOCKS ON THE MOVE-ResMed, Stryker, ALX Oncology
Lexicon Pharma tumbles on equity offering, private placement with top shareholder
Brief: Lexicon Announces Pricing Of Approximately $94.6 Million Public Offering At $1.30 Per Share
Lexicon Pharma slides after stock offering unveil
U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies
U.S. STOCKS ON THE MOVE-Teledyne, Arm Holdings, Nathan’s Famous